Melatonin and its derivatives
Authors:
- Kamoru A. AdedokunKAKamoru A. Adedokun
- Abida BhatABAbida Bhat
- Sikiru O. ImodoyeSISikiru O. Imodoye
- Saheed O. AnifowoseSASaheed O. Anifowose
- Hassanat T. FayemoHFHassanat T. Fayemo
- AbdulRaheem AdedejiAAAbdulRaheem Adedeji
- Ibrahim O. BelloIBIbrahim O. Bello
- Mujeeb O. ShittuMSMujeeb O. Shittu
- Ive-Anwuli Ralph-UyalorIRIve-Anwuli Ralph-Uyalor
- Malik A. SanusiMSMalik A. Sanusi
- 9 August 2024
- book chapter
- Published by Elsevier
- p. 197-238
Abstract
No abstract availableThis publication has 233 references indexed in Scilit:
- Melatonin impedes prostate cancer metastasis by suppressing MMP‐13 expressionJournal of Cellular Physiology, 2020
- Melatonin: A new inhibitor agent for cervical cancer treatmentJournal of Cellular Physiology, 2019
- Assessment of iron status and interplay between lipid peroxidation and antioxidant capacity in common hemoglobin variants in Osun State, southwestern NigeriaThe Kaohsiung Journal of Medical Sciences, 2019
- Phytotherapeutics in cancer invasion and metastasisPhytotherapy Research, 2018
- The neuroprotective role of melatonin in neurological disordersJournal of Neuroscience Research, 2018
- Tissue‐specific insulin signaling in the regulation of metabolism and agingIUBMB Life, 2014
- Growth‐Inhibitory Activity of Melatonin on Murine Foregastric Carcinoma Cells In Vitro and the Underlying Molecular MechanismThe Anatomical Record, 2013
- Role of CD4+CD25+ Regulatory T Cells in Melatonin‐Mediated Inhibition of Murine Gastric Cancer Cell Growth In Vivo and In VitroThe Anatomical Record, 2011
- Melatonin: Signaling mechanisms of a pleiotropic agentBioFactors, 2009
- Bioavailability of melatonin in humans after day-time administration of D7 melatoninBiopharmaceutics & Drug Disposition, 2000